PRNewsWire
23 Oct 2025, 14:00 UTC · 45w ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
2 claims · each scored for market impact
A class action lawsuit has been filed against Jasper Therapeutics, Inc. (JSPR) and certain officers alleging violations of federal securities laws. — Securities litigation creates legal uncertainty and potential financial liabilities, typically viewed negatively by investors.
-0.60The lawsuit covers a class period for securities purchases between November 30, 2023, and July 3, 2025. — The length of the class period defines the scope of potential damages and the number of affected shareholders.
-0.20Which stocks this story touches
The company is the subject of a class action lawsuit alleging violations of federal securities laws.
Continue reading
6 related stories
Top 3 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
1d ago
